Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
363250
vs
K
KOSPI 200
Over the past 12 months, GeneSystem Co Ltd has underperformed KOSPI 200, delivering a return of -32% compared to KOSPI 200's +125% growth.
Stocks Performance
363250 vs KOSPI 200
Performance Gap
363250 vs KOSPI 200
Performance By Year
363250 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
GeneSystem Co Ltd
Glance View
GeneSystem Co Ltd makes molecular diagnostic products used to detect infectious diseases. It develops and sells test kits and related reagents that help labs identify pathogens from human or animal samples. Its main customers are hospitals, clinical laboratories, research users, and veterinary testing businesses that need fast and reliable disease detection tools. The company earns money by selling diagnostic kits, assay reagents, and related testing products to those customers, often through distributors and direct sales channels. In this business, GeneSystem sits one step upstream from the lab: it turns biological testing methods into ready-to-use products that other organizations use in routine screening and diagnosis. What makes the business model different is that it depends on specialized scientific know-how, regulatory quality control, and repeat usage of consumable test products. Once a lab adopts a test platform, it typically keeps buying the kits and reagents needed to run it, which gives the company a steady product-based relationship with its customers.